ArticleNPJ digital medicine2026

Treatment-aware deep learning enables counterfactual prediction of individual benefit from PARP inhibitors in ovarian cancer.

Jean-Sébastien Frenel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.